HIPEC (Hyperthermic Intraperitoneal Chemotherapy) is an advanced treatment performed after cytoreductive surgery to destroy microscopic cancer cells remaining in the abdomen.
A heated chemotherapy solution (41–43°C) is circulated directly into the abdominal cavity, allowing higher local drug concentration and fewer side effects than traditional chemotherapy.
HIPEC helps extend survival and improve the quality of life for patients with certain abdominal cancers.

HIPEC is primarily used for cancers that spread to the lining of the abdominal cavity (peritoneum), including:

• Ovarian cancer (advanced or recurrent)

• Colorectal cancer with peritoneal metastases

• Appendiceal cancer (Pseudomyxoma Peritonei)

• Gastric cancer with peritoneal spread

• Primary peritoneal carcinoma

• Peritoneal mesothelioma